BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15377349)

  • 1. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
    Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
    Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do basal cell carcinomas recur after complete conventional surgical excision?
    Griffiths RW; Suvarna SK; Stone J
    Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small margin excision of periocular basal cell carcinomas.
    Chadha V; Wright M
    Br J Ophthalmol; 2009 Jun; 93(6):803-6. PubMed ID: 19304655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of periocular basal cell carcinoma managed by overnight paraffin section.
    Khandwala MA; Lalchan SA; Chang BY; Habib M; Chakrabarty A; Cassells-Brown A
    Orbit; 2005 Dec; 24(4):243-7. PubMed ID: 16354633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision.
    Griffiths RW
    Br J Plast Surg; 1999 Jan; 52(1):24-8. PubMed ID: 10343586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
    Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
    Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
    Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
    Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinomas: do they need to be followed up?
    Park AJ; Strick M; Watson JD
    J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.
    Shah SM; Konnikov N; Duncan LM; Tannous ZS
    Lasers Surg Med; 2009 Aug; 41(6):417-22. PubMed ID: 19588534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
    van der Meer GT; Willemse F; Marck KW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of basal cell carcinomas: an audit of current practice.
    Mc Loone NM; Tolland J; Walsh M; Dolan OM
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of incompletely excised basal cell carcinomas of the skin.
    Rippey JJ; Rippey E
    Med J Aust; 1997 Jun; 166(11):581-3. PubMed ID: 9201177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of incompletely excised basal cell carcinomas of the head and neck.
    Wilson AW; Howsam G; Santhanam V; Macpherson D; Grant J; Pratt CA; Townend JV
    Br J Oral Maxillofac Surg; 2004 Aug; 42(4):311-4. PubMed ID: 15225948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.